ERNA icon

Eterna Therapeutics
ERNA

Overview Fund Activity

24 hedge funds and large institutions have $292K invested in Eterna Therapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+4
Holders Change %
+20%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Geode Capital Management
Geode Capital Management
Massachusetts
$75.7K
2
XT
XTX Topco
Cayman Islands
$17.1K
3
Millennium Management
Millennium Management
New York
$13.2K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$9.16K
5
CSS
Cubist Systematic Strategies
Connecticut
$6.28K

Top Sellers

1
UBS Group
UBS Group
Switzerland
$4.96K
2
NW
Naviter Wealth
Arkansas
$13.9K
3
BWP
Baldwin Wealth Partners
Massachusetts
$0
4
SCA
Sippican Capital Advisors
Massachusetts
$14.7K
5
TRCT
Tower Research Capital (TRC)
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
– -$5.24K -333 Closed
Morgan Stanley
27
Morgan Stanley
New York
– -$53 -3 Closed
APC
28
Aspire Private Capital
North Carolina
– -$11 -1 Closed
1
2